Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) - Test2 - elhamkhani - TriplyDB

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

http://www.wikidata.org/entity/Q24633690

about

A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo Engineered IgG1-Fc--one fragment to bind them all TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Cellular self-defense: how cell-autonomous immunity protects against pathogens Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structure of the rhesus monkey TRIM5 PRYSPRY domain, the HIV capsid recognition module Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity The Peculiar Characteristics of Fish Type I Interferons Coordinated Neutralization and Immune Activation by the Cytosolic Antibody Receptor TRIM21 Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family Antibodies against alpha-synuclein reduce oligomerization in living cells Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium.UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.Mass spectrometric and peptide chip characterization of an assembled epitope: analysis of a polyclonal antibody model serum directed against the Sjøgren/systemic lupus erythematosus autoantigen TRIM21.Polarized cell migration during cell-to-cell transmission of herpes simplex virus in human skin keratinocytes.PKA-dependent dynein switching from lysosomes to adenovirus: a novel form of host-virus competition.Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies FTR83, a Member of the Large Fish-Specific finTRIM Family, Triggers IFN Pathway and Counters Viral Infection.Role of Fc in antibody-mediated protection from ricin toxin Which Antibody Functions are Important for an HIV Vaccine?Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet's disease.Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.TRIM21 is critical for survival of Toxoplasma gondii infection and localises to GBP-positive parasite vacuoles.Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish Interferon-inducible effector mechanisms in cell-autonomous immunity.QTL for white spot syndrome virus resistance and the sex-determining locus in the Indian black tiger shrimp (Penaeus monodon)Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells.Intracellular sensing of complement C3 activates cell autonomous immunity.Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogens Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies IgG subclasses and allotypes: from structure to effector functions.TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation.The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.Polyreactivity and autoreactivity among HIV-1 antibodies.Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo

P2860

Q24619754-3629C1D3-B091-448D-9041-952175028F9B Q26766715-22A4B39A-EBDF-4850-942B-51FE2C57AF16 Q26779753-E5455E24-3DC7-48FE-871E-DF8BB700AE10 Q26783175-B327DC71-AB60-4004-BD08-B80365CDF977 Q26864521-61D7B4D0-71F1-4188-8083-B5D6AFBD2A0F Q27316185-C8CAD69E-C44F-458A-874C-F1D72F1BA83D Q27322604-C19287D8-8A9F-4055-B38B-C67B2BA91517 Q27654848-185AA52D-DC1B-4144-92AD-4829C9B71630 Q27670990-E3D60E4F-6044-42FA-895F-E01AD53E718F Q27678419-88F97C32-8297-46C0-86DC-1236503B7587 Q28072692-CE038A7F-564F-4FA7-BE76-E4E79530B130 Q28078936-AF8C1A54-7927-436E-B442-B8696CE0F761 Q28554212-A51B5956-477B-4DE7-90AD-8EF1DB194C00 Q28661395-09F5CE39-44D9-4B9A-9A6F-4E3D5ABD3B44 Q28743313-0FF02389-F836-4B69-83A8-DAE109A8CCF3 Q30397773-5D515F1F-86CD-443D-AEBC-7F4FE95D143E Q30414377-3117DBCE-89E6-4D4A-A6C9-4E14A6DA025D Q30431292-3770F907-3072-4948-B916-AEB48F0B8A64 Q30541128-34AA7AE5-3572-461C-A7F2-EEDC5B01862D Q30577235-E1529A53-3C1A-43BD-A228-87D337FFEBE5 Q33686907-A05872DC-AF68-4600-975F-44354FF5A43D Q33729303-0DD0223B-99F5-489D-AC24-697E1DFED83B Q33736516-9D765E66-BFA5-4A25-8D7C-A09A17150535 Q33772637-F2986BB1-2ED1-4C4C-A5FD-99C86B82B4EC Q33774072-EA619FB7-398A-419E-B4E6-C765507E00E7 Q33867299-AC719B7D-B733-4573-9127-A59BF2791771 Q33899190-E6B84AED-96C7-4FD3-B9C0-73AC9800BABA Q33971228-E5284C10-86EA-43B8-A39E-3CD51421B674 Q34114819-4F9BBA0E-9759-418C-8520-22251BF85F0B Q34151113-9804F1DF-273F-4907-AB66-DD675B73055D Q34186473-3F58A1EF-E747-4421-8E35-788E6D990F62 Q34217953-5E0A1F16-1757-4937-8FA6-D9981394E34A Q34231523-1A8D489F-F91F-436C-9801-D00D86A91513 Q34319249-CEBBE707-020E-4B1F-807F-EA6FE0C2E52E Q34324992-E1D55227-5B43-4E98-A767-743AAE58ACAE Q34368678-352CCA4F-C0A7-4186-8B4F-0B85B60E894E Q34442208-5F91E436-6B26-407E-A8AA-489FB76E5F37 Q34677183-958E3543-0EF6-46C6-AD3E-3A183B5D1EE4 Q34992787-494BFCD1-0D5B-47BC-B8E1-8AAB413A953D Q35295003-AD006EAB-3ADD-4CD7-97DA-C69E19A3C76B

P2860

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

http://www.wikidata.org/entity/Q24633690

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@ast

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@en

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@nl

type

label

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@ast

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@en

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@nl

prefLabel

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@ast

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@en

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@nl

P1433

Q24633690-DD3E50DC-B9D8-4FA6-9CF7-9EAAC45D7E18

P1476

Q24633690-7C4B7C5C-8C77-400F-9DA8-C284BF7C31E0

P2093

Q24633690-2B176E5E-7C4C-4D8F-9762-7B91BD40E796

Q24633690-693CBF1A-046D-4435-8AF1-1E5717B43399

Q24633690-69CCBD8F-C727-4B63-96F3-6F3944FB4880

P2860

Q24633690-0E3BE2FD-ABEA-4614-AA5F-288A4C1191BF

Q24633690-1CD2CB3C-9D6E-49AE-996C-4B1955050E7B

Q24633690-1D8959AC-2E45-4464-AD81-2C2C22597EF3

Q24633690-24B4D153-9769-42B8-A6F6-013012155133

Q24633690-2592D346-1DC0-4B8F-823E-10652E6CDC45

Q24633690-3B45CE4A-E45F-477C-A561-0A8765E2AE50

Q24633690-43CA2FAD-1880-4ECC-BED0-68553B2EA985

Q24633690-5F4F780B-5619-4056-8421-B8385EFF8366

Q24633690-6B179343-3F02-45D6-829B-BF32D82FE635

Q24633690-735EFAA2-FDA2-4391-9950-1F4F0BCC586D

P304

Q24633690-0449E564-F243-4EFB-B8DD-8D757C58B054

P31

Q24633690-5961041F-2986-4922-A620-33B9E6225CD9

P3181

Q24633690-B1302966-FC9B-44EC-8A43-B31057106BDE

P356

Q24633690-77696E6C-0480-456C-B7A5-9F29BA6AA3DB

P407

Q24633690-01B094A1-4F26-40A4-BE34-9AD9BB696404

P433

Q24633690-901557B0-16D0-4591-B993-F6D64B718CC7

P478

Q24633690-D4E4AA0F-2BF1-4829-B790-8C8BEFED5144

P50

Q24633690-57A5AAD2-46E1-47CC-9A04-443BD3D27E3A

Q24633690-AB3B0330-F929-4FE4-B32B-5C7E1DCD6B1C

Q24633690-FCDD9E81-3A20-4569-9C19-9C5EB25EC57E

P577

Q24633690-0D7AD5A0-1FEC-4445-8347-093A028F7FF8

P5875

Q24633690-4D04C2A1-D0FA-4583-9E5F-BC08CA4DB12A

P698

Q24633690-273314D6-D8B0-48D4-801C-1A379C6DCDDF

P921

Q24633690-03EDC27C-2855-480F-B623-D2C762E4C8AB

P932

Q24633690-D2D89496-C899-4F7A-AD72-3E2DF216DA5E

P3181

P356

PNAS.1014074107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

@en

P2093

Chris M Johnson

http://www.w3.org/2001/XMLSchema#string

Donna L Mallery

http://www.w3.org/2001/XMLSchema#string

Leo C James

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function

TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved

Pathogen recognition and innate immunity

Retroviral restriction factor TRIM5alpha is a trimer

Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.

Postabsorption neutralization of poliovirus

Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.

Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection.

P304

19985-19990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3047303

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1014074107

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

William A. McEwan

Susanna R Bidgood

P577

2010-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47661060

http://www.w3.org/2001/XMLSchema#string

P698

21045130

http://www.w3.org/2001/XMLSchema#string

P921

P932

2993423

http://www.w3.org/2001/XMLSchema#string